Post-traumatic stress and psychosis: three psychotherapies reduce trauma symptoms

Treating trauma in someone who also has a psychotic disorder can reduce their post-traumatic stress symptoms without necessarily improving psychosis. In the RE.PROCESS trial, three psychotherapies delivered alongside usual care achieved better results than a waiting list. These findings involve 162 participants and need confirmation in larger samples.

Illustration of a psychotherapy session in a consulting room.
MindsetEditorial illustration, not study data.

Three therapies compared with a waiting list

This multicenter trial included people with post-traumatic stress disorder (PTSD) and a history of a schizophrenia-spectrum psychotic disorder. Participants were randomly assigned to four groups: prolonged exposure, EMDR therapy, cognitive restructuring or a waiting list.

All groups continued their usual care. The psychotherapies involved a maximum of 16 sessions, delivered twice a week. Follow-up extended to six months after group assignment. Assessors did not know which group participants had been assigned to.

The primary outcome was PTSD severity, measured by an assessor using the CAPS-5, a dedicated clinical scale. The trial therefore primarily aimed to measure changes in trauma symptoms, not psychosis.

Reduced trauma symptoms at six months

At six months, all three therapies were associated with significantly lower PTSD severity than in the waiting-list group. Adjusted differences on the CAPS-5 were −9.76 points for prolonged exposure, −11.74 points for EMDR and −12.72 points for cognitive restructuring.

The 95% confidence intervals were −16.13 to −3.38 points, −18.04 to −5.44 points and −18.89 to −6.55 points, respectively. The authors describe large effect sizes. However, these average differences between groups do not predict how much any individual will benefit.

These results do not establish a winning therapy: the abstract reports comparisons with the waiting list, not demonstrated superiority of one psychotherapy over the other two. No significant effect on psychotic symptoms was found.

A case for access to care, not unqualified proof

The trial supports offering trauma-focused therapies to this population. It does not show that they replace treatment for the psychotic disorder: they were added to usual care.

The comparator was a waiting list, not another active psychotherapy. The study therefore cannot fully separate the specific effects of the techniques from those of therapeutic support. The reported follow-up ends at six months.

Only the PubMed abstract is available in the source material. It details neither adverse effects nor treatment dropouts, so the observed efficacy is not enough to draw conclusions about tolerability.

Limitations to keep in mind

A sample of 162 participants, comparison with a waiting list and follow-up limited to six months. Full text not consulted. Adverse effects, dropouts, funding and conflicts of interest cannot be verified from the supplied abstract.

What we can take away

In people with PTSD and a psychotic disorder, these three psychotherapies reduce trauma symptoms compared with waiting while receiving usual care. This demonstrates neither an improvement in psychosis nor the superiority of any one technique.

Sources and provenance

Partager cet article

X f in

An error or a source to report? Contact the editorial team.